SINGAPORE, May 20 (Xinhua) -- AstraZeneca will invest 1.5 billion U.S. dollars in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs), the biopharmaceutical giant ...
AstraZeneca says it will invest 1.5 billion U.S. dollars in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs). AstraZeneca says it will invest 1.5 billion U.S. dollars ...